Publication | Closed Access

Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer

NanomedicineDrug TargetingEngineeringPolymer-drug ConjugatePlasmid Porf-htrailNano-drug DeliveryTumor TargetingBiomedical EngineeringPeptide-conjugated Polyamidoamine DendrimerDrug Delivery SystemPharmacology